Avesta Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 16-06-2024
- Paid Up Capital ₹ 2.00 Cr
as on 16-06-2024
- Company Age 15 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 55.90 Cr
as on 16-06-2024
- Satisfied Charges ₹ 25.91 Cr
as on 16-06-2024
- Revenue 52.18%
(FY 2023)
- Profit 139.32%
(FY 2023)
- Ebitda 125.53%
(FY 2023)
- Net Worth 224.25%
(FY 2023)
- Total Assets 57.58%
(FY 2023)
About Avesta Pharma
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹55.90 Cr. The company has closed loans amounting to ₹25.91 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kersi Tangri, Mahesh Doshi, Eric Tangri, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24239MH2009PTC192677
- Company No.
192677
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 May 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Avesta Pharma?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amol Walke  | Director | 01-Apr-2015 | Current |
Kersi Tangri  | Director | 25-May-2009 | Current |
| Mahesh Doshi | Director | 01-Apr-2015 | Current |
| Eric Tangri | Additional Director | 04-Apr-2024 | Current |
| Zubin Gandhi | Director | 30-Nov-2009 | Current |
Financial Performance and Corporate Structure Insights of Avesta Pharma.
Avesta Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 52.18% increase. The company also saw a substantial improvement in profitability, with a 139.32% increase in profit. The company's net worth Soared by an impressive increase of 224.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avesta Pharma?
In 2023, Avesta Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hildose Pharmaspecialities LlpActive 4 years 10 monthsKersi Tangri and Eric Tangri are mutual person
Esteem Industries Private LimitedActive 22 years 11 monthsZubin Gandhi and Amol Walke are mutual person
Biesterfeld Hildose Speciality Chemicals Private LimitedActive 1 year 1 monthKersi Tangri is a mutual person
Accusynth Speciality Chemicals Private LimitedActive 45 years 8 monthsKersi Tangri and Mahesh Doshi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 Aug 2021 | ₹55.90 Cr | Open |
Bank Of India Creation Date: 18 Aug 2011 | ₹18.00 Cr | Satisfied |
Bank Of India Creation Date: 18 Aug 2011 | ₹7.91 Cr | Satisfied |
How Many Employees Work at Avesta Pharma?
Avesta Pharma has a workforce of 124 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avesta Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avesta Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
